NOV 27, 2019 4:40 PM PST

3D-printed cell traps catch cancer cells on the move

WRITTEN BY: Tara Fernandez

The early stages of metastasis, or the spread of cancer cells from the primary tumor site, are incredibly difficult to detect by analyzing blood samples. For a 10 milliliter sample, this would mean positively identifying a mere handful of cancerous cells amidst 50 million blood cells.

A. Fatih Sarioglu and collaborating investigators at the Georgia Institute of Technology are turning to 3D-printing technology for solutions — using cell traps to narrow the analysis pool, making cancer cells considerably easier to spot.

In research published in the journal Lab on a Chip, the team from the School of Electrical and Computer Engineering (ECE) designed devices with intricate layers of microfluidic channels, through which a patient’s blood sample would flow through. The architecture of the fluid path extracts larger cells (such as white blood cells and cancer cells), letting smaller red blood cells continue to flow through. 

Analyzing just the subpopulation of trapped cells makes the cancer diagnostic process significantly simpler, faster and cheaper. The instrument is also designed to be gentle enough to keep any captured tumor cells completely intact — a critical design feature to maximize diagnostic accuracy.

As tumors advance, they can begin to migrate to distant sites in the body by invading into surrounding tissue structures, traveling with the flow of the lymphatic system, or via the blood circulation. Wide-spread tumor metastasis dramatically decreases a patient’s chance of survival, making early warnings potentially life-saving. 

For instance, just over 50 percent of patients with lung cancer are expected to live five years past diagnosis. At later stages of cancer, metastasis causes this rate to drop to just 5 percent.

To evaluate the effectiveness of their new technology, the researchers spiked healthy blood samples with known numbers of cancer cells and ran the samples through the device. Results indicated that the device was highly effective, having snared 90 percent of tumor cells.

The device was also found to be successful in catching circulating cancer cells in small amounts of blood drawn from patients with metastatic prostate cancer.

Future iterations of the device will focus on further simplifying its design and boosting its performance and manufacturability. 

It is anticipated that commercializing this technology would be a big step up for the future of personalized medicine by allowing clinicians to detect red flags and execute treatment strategies against metastatic cancer earlier and more effectively.

 

Sources: Science Daily, Futurity, Lab on a Chip

Photo credit: Allison Carter, Georgia Tech

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 27, 2020
Immunology
Thymus Transplantation?! It Could be Possible!
DEC 27, 2020
Thymus Transplantation?! It Could be Possible!
The thymus is an essential organ of the lymphatic system; it is responsible for developing mature T cells. T c ...
DEC 23, 2020
Cancer
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
DEC 23, 2020
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
Brain cancer is an incredible challenge for modern medicine. Most drugs don’t make it past the blood-brain barrier ...
DEC 23, 2020
Clinical & Molecular DX
Smartphone Device Uses CRISPR to Check for COVID
DEC 23, 2020
Smartphone Device Uses CRISPR to Check for COVID
Quick, portable, and ultrasensitive—a new smartphone test for COVID-19 checks all the boxes needed to get a handle ...
DEC 28, 2020
Drug Discovery & Development
Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells
DEC 28, 2020
Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells
Glioblastoma is a very aggressive and lethal form of brain cancer that responds poorly to chemotherapy in children and a ...
JAN 06, 2021
Clinical & Molecular DX
COVID Patients Can't Stop and Smell the Roses
JAN 06, 2021
COVID Patients Can't Stop and Smell the Roses
A study of over 2,500 European patients has revealed that 85.9 percent of those with mild COVID-19 symptoms lost their s ...
JAN 07, 2021
Health & Medicine
How Cannabis Might Help Fibromyalgia
JAN 07, 2021
How Cannabis Might Help Fibromyalgia
Fibromyalgia affects as many as 4 million adults in America  (2 percent of the adult population) and is a debilitat ...
Loading Comments...